Jun 2026 (Q2 FY26) — Sep 9, 2026
Nano-X Imaging Q2 FY26 — Strategic Restructuring and Commercial Expansion
Read the full callNano-X Imaging earnings: last reported Wed, 9 Sep 2026, for the quarter ended Jun 2026.
Price
1Y: $3.99 on 17 Oct 2025 → $0.41. High $4.55 (26 Nov 2025), low $0.41 (19 Oct 2026).
Overview
Call summaries
Nano-X Imaging Q2 FY26 — Strategic Restructuring and Commercial Expansion
Read the full callNano-X Imaging Ltd. Q1 FY26 — Strategic Shifts Amidst Revenue Guidance Withdrawal and Going Concern Warning
Read the full callEvery analysed call
Financials
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | -41 | -84 | -146 | -259 | -320 | -374 | -449 |
| Total liabilities | — | 21 | 5 | 71 | 37 | 23 | 21 | 22 |
| Fixed assets | — | 0 | 14 | 37 | 44 | 42 | 45 | 30 |
| Investments | — | — | — | 22 | 39 | 26 | 18 | — |
| Total assets | — | 12 | 236 | 363 | 254 | 219 | 210 | 162 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -4 | -6 | -22 | -38 | -43 | -45 | -37 | -41 |
| Cash from investing | -0 | -0 | -14 | -116 | 15 | 35 | -20 | 29 |
| Cash from financing | 4 | 14 | 241 | 7 | 1 | 27 | 40 | 21 |
| Net cash flow | -0 | 8 | 206 | -147 | -28 | 18 | -17 | 10 |
| Capital expenditure | -0 | -0 | -14 | -23 | -7 | -3 | -3 | -4 |
| Free cash flow | -4 | -6 | -36 | -61 | -51 | -48 | -39 | -45 |
20 filings between Mar 18, 2026 and Oct 14, 2026.
Purchases
$179.4K
9 purchases by 3 insiders
Sales
$1.1K
2 sales by 1 insider
Also filed: 2 dispositions to the issuer.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Suesskind Dan S | $91.8K | — | Sep 14, 2026 |
| Meltzer Erez | $57.9K | — | Sep 15, 2026 |
| Kainan Noga | $29.7K | — | Jul 28, 2026 |
| Alroy Erez | — | $1.1K | Jun 10, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 14, 2026 | Yahav Attias Gali Chief Corporate Resources | Award | 28,283 | $0 |
| Oct 14, 2026 | saban sharon General Manager AI Division | Award | 28,283 | $0 |
| Oct 14, 2026 | Nathansohn Guy Chief Financial Officer | Award | 50,000 | $0 |
| Oct 13, 2026 | Gofman Feler Marina Chief Legal Officer | Award | 28,283 | $0 |
| Oct 11, 2026 | Aharon Cohen Tamar EVP & Chief Marketing Officer | Award | 28,283 | $0 |
| Oct 11, 2026 | Dara James GM Source & Services Division | Award | 28,283 | $0 |
| Oct 10, 2026 | Koren Ofir General Manager, ARC Division | Award | 28,283 | $0 |
| Sep 15, 2026 | Meltzer Erez Chief Executive Officer | Purchase | 10,000 | $6.9K |
| Sep 14, 2026 | Suesskind Dan S Director | Purchase | 30,000 | $22.8K |
| Sep 14, 2026 | Suesskind Dan S Director | Purchase | 30,000 | $22.5K |
| Sep 10, 2026 | Meltzer Erez Chief Executive Officer | Purchase | 10,000 | $7.8K |
| Aug 10, 2026 | Meltzer Erez Chief Executive Officer | Purchase | 9,443 | $9.7K |
| Jul 29, 2026 | Daniel Ran CFO | Disposition to issuer | 1,000 | $890 |
| Jul 28, 2026 | Kainan Noga Director | Purchase | 33,000 | $29.7K |
| Jul 27, 2026 | Suesskind Dan S Director | Purchase | 25,000 | $23.0K |
| Jul 27, 2026 | Suesskind Dan S Director | Purchase | 25,000 | $23.5K |
| Jul 27, 2026 | Meltzer Erez Chief Executive Officer | Purchase | 36,000 | $33.5K |
| Jun 10, 2026 | Alroy Erez Director | Sale | 469 | $774 |
| Jun 10, 2026 | Alroy Erez Director | Sale | 209 | $345 |
| Mar 18, 2026 | Daniel Ran CFO | Disposition to issuer | 39,474 | $0 |
| Sep 5, 2025 | Daniel Ran CFO | Purchase | 1,000 | $3.6K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Nano-X Imaging Ltd. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading